Access cutting-edge cerebral amyloid angiopathy treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Orange location
Access cerebral amyloid angiopathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cerebral amyloid angiopathy treatment provided free
Check if you qualify for this cerebral amyloid angiopathy clinical trial in Orange, CA
No-Cost Study Care
Local to Orange
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of the study is to evaluate the effect of ALN-APP on measures of CAA disease progression and to characterize the safety, tolerability, and pharmacodynamics (PD) of ALN-APP in adult patients with sporadic CAA (sCAA) and Dutch-type CAA (D-CAA). The study will be conducted over 2 periods: a 24-month double-blind treatment period and an optional 18-month open-label extension (OLE) period. The estimated duration of study participation, inclusive of screening, treatment, and additional saf
Sponsor: Alnylam Pharmaceuticals
Yes, this clinical trial (NCT06393712) has an active research site in Orange, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for cerebral amyloid angiopathy treatment options in Orange, CA, this clinical trial (NCT06393712) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cerebral amyloid angiopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all cerebral amyloid angiopathy clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Orange — not just this study.
Browse Rheumatoid Arthritis Trials in Orange →